A Phase I/II Trial of Trastuzumab plus Erlotinib in Metastatic HER2-Positive Breast Cancer: A Dual ErbB Targeted Approach

✍ Scribed by Carolyn D. Britten; Richard S. Finn; Linda D. Bosserman; Steven G. Wong; Michael F. Press; Mubashira Malik; Bert L. Lum; Dennis J. Slamon

• Book ID: 115075826
• Publisher: CIG Media Group, LP.
• Year: 2009
• Tongue: English
• Weight: 119 KB
• Volume: 9
• Category: Article
• ISSN: 1526-8209
• DOI: 10.3816/cbc.2009.n.003